Background
There is a lack of evidence on the clinical effectiveness of hydrodistension for frozen shoulder following failed conservative management.
Methods
A total of 90 patients opted for hydrodistension following failed initial treatment which included physiotherapy and at least one corticosteroid injection. Shoulder pain and function were assessed at baseline, and 6, 12 and 24 weeks using the Shoulder Pain Disability Index (SPADI), The Upper Extremity Functional Index (UEFI) and a visual analogue scale (VAS) for pain. Active ranges of motion were assessed at baseline, post‐24 hr and discharge.
Results
We observed clinically important improvements in pain (VAS −5.5; 90% confidence interval [CI] −6.0 to −5.0; SPADI pain, −20; 90% CI−23 to −17) and function (UEFI 23; 90% CI 19 to 26; SPADI disability, −32; 90% CI −36 to −28) at 6 weeks. These improvements remained clearly substantial at 24 weeks. Active range of motion improved substantially post‐24 hr (flexion 20, 90% CI 18 to 23; lateral rotation 14, 90% CI 12 to 16; abduction 22, 90% CI 19 to 25) and at discharge (flexion 37, 90% CI 33 to 41; lateral rotation 24, 90% CI 21 to 27; abduction 44, 90% CI 38 to 50).
Discussion
This single‐arm observational study suggests that hydrodistension is an effective treatment of frozen shoulder within a UK primary care setting when standard treatment has failed.